Table 1 Oocyte quality predictors
From: Oocyte zona pellucida dysmorphology is associated with diminished in-vitro fertilization success
Dysmorphic oocytes | Normal oocytes | Dysmorphic vs. Normal | Dysmorphic vs. Normal oocytes 4 | |
|---|---|---|---|---|
Diff 1 /RR 2 / IRR 3 [95% CI] | Difference 1 /RR 2 / IRR 3 [95% CI] | |||
N = 119 | N = 77 | P-value | P-value | |
Age | 35.5 (3.9) | 34.3 (4.1) | 1.2 [0.05,2.4] | |
Mean (SD) | P = 0.040 | |||
AMH ng/ml | 2.5 (2.0) | 2.3 (1.5) | 0.2 [−0.9, 1.2] | −0.1 [−1.2, 0.9] |
Mean (SD) | P = 0.762 | P = 0.795 | ||
FSH IU/l | 6.0 (2.5) | 6.8 (2.3) | −0.8 [−1.7, 0.2] | −0.8 [−1.7, 0.2] |
Mean (SD) | P = 0.115 | P = 0.120 | ||
Total Gonadotropin dose IU | 3847.4 (1791.8) | 3128.2 (1842.4) | 719 [184, 1254] | 525 [12, 1038] |
Mean (SD) | P = 0.009 | P = 0.045 | ||
Peak Estradiol Pg/ml | 2760.6 (1346.4) | 3157.4 (1377.6) | −396.8 [−802.7, 9.1] | −345.5 [−753.8, 62.8] |
Mean (SD) | P = 0.055 | P = 0.097 | ||
Oocytes retrieved per cycle | 10.3 (5.4) | 12.8 (5.4) | −2.5 [−4.0, −0.9] | −2.2 [−3.7, −0.6] |
Mean (SD) | P = 0.002 | P = 0.007 | ||
% M2 oocytes | 78.0% (17.9%) | 81.3 (17.9%) | −3.3% [−8.4%, 1.9%] | −3.4% [−8.6%, 1.8%] |
Mean (SD) | P = 0.214 | p = 0.196 | ||
Long Agonist cycles | 45% | 68% | 0.005 | |
Short Antagonist cycles | 25% | 18% | ||
Short Flare cycles | 31% | 14% |